These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19661356)

  • 1. MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.
    Fukushima T; Iwao H; Nakazima A; Miki M; Sakai T; Sawaki T; Tanaka M; Masaki Y; Hirose Y; Umehara H
    Anticancer Res; 2009 Aug; 29(8):3361-4. PubMed ID: 19661356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent methicillin-resistant Staphylococcus aureus septicemia and pyomyositis in a patient with dengue hemorrhagic fever: a case report.
    Ehelepola NDB; Rajapaksha RKGM; Dhanapala DMUB; Thennekoon TDK; Ponnamperuma S
    BMC Infect Dis; 2018 Feb; 18(1):99. PubMed ID: 29486726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of arbekacin in deep MRSA infection. Including follow-up study after the termination of chemotherapy].
    Kuwabara M; Konishi F; Yokoyama T; Kodama T; Santoh T; Nakai S; Miyoshi N; Kurimura T; Miyazawa T; Arita K
    Jpn J Antibiot; 1994 Jun; 47(6):771-80. PubMed ID: 8072186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methicillin-resistant Staphylococcus aureus-induced pyomyositis that emerged during recovery from drug-induced pancytopenia].
    Kobayashi S; Kimura F; Ogura K; Kobayashi A; Torikai H; Ikeda T; Sato K; Saionji K; Ito T; Saito D; Motoyoshi K
    Rinsho Ketsueki; 2008 Jan; 49(1):55-8. PubMed ID: 18277598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
    Hayashi I; Inoue M; Hashimoto H
    Drugs Exp Clin Res; 1994; 20(6):225-32. PubMed ID: 7758394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpartum iliopsoas pyomyositis due to community-acquired methicillin-resistant Staphylococcus aureus.
    Sokolov KM; Kreye E; Miller LG; Choi C; Tang AW
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):535-8. PubMed ID: 17666656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyomyositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia.
    Chiu SK; Chang FY
    Int J Infect Dis; 2009 May; 13(3):e85-7. PubMed ID: 18848798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage regimen of arbekacin for methicillin-resistant Staphylococcus aureus infection in newborns and infants.
    Yoshida K; Minowa H; Ebisu R; Uchida Y; Takahashi Y; Yoshioka A
    Pediatr Int; 2004 Dec; 46(6):645-9. PubMed ID: 15660861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
    Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
    Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies on methicillin-resistant Staphylococcus aureus (MRSA) infections].
    Okumura A; Muraishi Y; Tsuritani S; Sakamoto M; Kazama T; Fuse H; Katayama T
    Hinyokika Kiyo; 1993 Dec; 39(12):1157-61. PubMed ID: 8285164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli pyomyositis in an immunocompromised host.
    Sharma U; Schwan WR; Agger WA
    WMJ; 2011 Aug; 110(4):182-4. PubMed ID: 22413629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
    Okada K; Kimura T; Mikamo H; Kasahara K; Seki M; Takakura S; Tokimatsu I; Ohmagari N; Takahashi Y; Matsumoto K; Igarashi M; Kobayashi M; Hamada Y; Mochizuki T; Kimura M; Nishi Y; Tanigawara Y; Takesue Y; ;
    J Infect Chemother; 2014 Jan; 20(1):1-5. PubMed ID: 24486168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of aminoglycoside response against methicillin-resistant Staphylococcus aureus infection in burn patients by artificial neural network modeling.
    Yamamura S; Kawada K; Takehira R; Nishizawa K; Katayama S; Hirano M; Momose Y
    Biomed Pharmacother; 2008 Jan; 62(1):53-8. PubMed ID: 18083323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study.
    Matsumoto T; Hanaki H; Kimura T; Nemoto M; Higashihara M; Yokota H; Oda S; Akiyama N; Miyao N; Yoshida M; Yukioka T; Soma K; Ohyashiki K; Suzuki Y; Arai T; Ikegami K; Ichiwata T; Otsuka Y; Kobayashi M; Totsuka K; Sunakawa K;
    J Infect Chemother; 2013 Feb; 19(1):128-37. PubMed ID: 23263188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An immunocompromised man with a fever].
    Stapel SN; Zweegman S
    Ned Tijdschr Geneeskd; 2011; 155(18):A1700. PubMed ID: 21429253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive pyomyositis secondary to paronychia-related MRSA infection: A case report.
    Wong YC; Chen HC; Lai CC
    Medicine (Baltimore); 2022 Jan; 101(2):e28431. PubMed ID: 35029183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of arbekacin on MRSA infections].
    Ichiyama S; Shimokata K
    Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical presentation of diffuse tropical pyomiositis of the psoas due to methicillin resistant Staphylococcus aureus].
    Ticse R; Melgarejo W; Fuentes-Dávila A; Ortíz J; Zegarra J
    Rev Peru Med Exp Salud Publica; 2012 Mar; 29(1):135-8. PubMed ID: 22510919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.